JW Lifescience Corporation

A234080

KR7234080000

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
12,090 ^KRW	-0.08%		+0.17%	-6.06%

2023	JW Lifescience Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	JW Lifescience Corporation(KOSE:A234080) dropped from S&P Global BMI Index	CI

JW Lifescience Corporation authorizes a Buyback Plan.

March 28, 2021

On March 29, 2021, the company has authorized a buyback plan.

Latest news about JW Lifescience Corporation

JW Lifescience Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
JW Lifescience Corporation(KOSE:A234080) dropped from S&P Global BMI Index	21/03/22	CI
JW Lifescience Corporation(KOSE:A234080) added to S&P Global BMI Index	20/09/21	CI
Tranche Update on JW Lifescience Corporation's Equity Buyback Plan announced on March 29, 2021.	29/04/21	CI
Tranche Update on JW Lifescience Corporation's Equity Buyback Plan announced on March 29, 2021.	29/04/21	CI
JW Lifescience Corporation's Equity Buyback announced on March 29, 2021, has closed with 350,000 shares, representing 2.21% for KRW 6,748.52 million.	25/04/21	CI
JW Lifescience Corporation(KOSE:A234080) dropped from S&P Global BMI Index	05/04/21	CI
JW Lifescience Corporation announces an Equity Buyback for 350,000 shares.	29/03/21	CI
JW Lifescience Corporation authorizes a Buyback Plan.	28/03/21	CI
JW Lifescience Corporation(KOSE:A234080) added to S&P Global BMI Index	18/09/17	CI
JW Life Science Co. Ltd. has completed an IPO in the amount of KRW 72 billion.	24/10/16	CI
JW Life Science Co. Ltd. has filed an IPO in the amount of KRW 78 billion.	09/09/16	CI
JW Holdings Corporation acquired an additional stake in JW Life Science Co. Ltd for KRW 28.8 billion.	01/06/15	CI
JW Holdings Corporation acquired remaining 32.07% stake in Jw Life Science Corporation for KRW 72.3 billion.	14/06/13	CI
An unknown buyer acquired 60.66% stake in JW Life Science Corporation from JW Holdings Corporation for KRW 91 billion.	14/06/13	CI

Chart JW Lifescience Corporation

Duration

Period

More charts

JW Life Science Co. Ltd. is a Korea-based company primarily engaged in manufacture and distribution of Intravenous (IV) fluid products and infusion solutions. The Company is engaged in manufacture of basic IV fluid including water, electrolytes and glucose; nutrient infusion solution including amino acids, lipids, proteins, vitamins and minerals; and special infusion solution, which is used in special cases. The Company is also engaged in manufacture of total parenteral nutrition (TPN) products and others.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JW LIFESCIENCE CORPORATION	-6.06%	136M
ELI LILLY AND COMPANY	+45.82%	765B
NOVO NORDISK A/S	+40.95%	632B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.45%	248B
ROCHE HOLDING AG	-0.78%	219B
NOVARTIS AG	+11.88%	216B
AMGEN INC.	+5.90%	164B

Other Pharmaceuticals